Literature DB >> 17208941

Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.

Kok-Min Seow1, Chi-Chang Juan, Low-Tone Ho, Yung-Pei Hsu, Yu-Hung Lin, Lee-Wen Huang, Jiann-Loung Hwang.   

Abstract

BACKGROUND: The aim of this study was to investigate serum and adipocyte mRNA expression of resistin in lean and obese women with polycystic ovary syndrome (PCOS) before and 3 months after laparoscopic ovarian electrocauterization (LOE).
METHODS: Adipose tissue obtained from 12 women with PCOS (six obese and six lean, body mass index > 27 kg m(-1) as threshold point) before and after LOE was analysed. Gene expression of resistin was measured by semi-quantitative RT-PCR. Ten lean, age-matched healthy women served as controls.
RESULTS: Both lean and obese women with PCOS had significantly higher fasting and 2 h insulin and homeostasis model insulin resistance index (HOMA(IR)) values and lower fasting glucose-to-insulin ratios (G(0)/I(0)) than did the controls. The serum levels of glucose and insulin and HOMA(IR) were significantly decreased, and the G(0)/I(0) ratio was significantly increased 3 months after LOE. No difference was found in serum resistin levels between controls and either obese or lean women with PCOS before LOE, nor between PCOS patients before and after LOE. However, resistin mRNA expression levels in both lean and obese women with PCOS before LOE were significantly higher than that in controls and were decreased significantly after LOE back to control levels.
CONCLUSION: Local resistin activity may be actively involved in the pathogenesis of PCOS. LOE reduces insulin resistance and down-regulates resistin mRNA expression in lean and obese women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208941     DOI: 10.1093/humrep/del489

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance.

Authors:  Yongli Chu; Qing Cui; Guijiao Feng; Zhiyun Song; Xueqiang Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

2.  Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.

Authors:  Charlotta J Olsen; José Moreira; Eugene M Lukanidin; Noona S Ambartsumian
Journal:  BMC Cancer       Date:  2010-08-19       Impact factor: 4.430

3.  Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.

Authors:  Sanaz Mehrabani; Arman Arab; Elham Karimi; Mehran Nouri; Marjan Mansourian
Journal:  Reprod Sci       Date:  2021-09-01       Impact factor: 2.924

4.  Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.

Authors:  Fatemeh Farshchian; Fahimeh Ramezani Tehrani; Houshang Amirrasouli; Hooman Rahimi Pour; Mehdi Hedayati; Faranak Kazerouni; Adeleh Soltani
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

Review 5.  Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models.

Authors:  Anthony Estienne; Alice Bongrani; Maxime Reverchon; Christelle Ramé; Pierre-Henri Ducluzeau; Pascal Froment; Joëlle Dupont
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

Review 6.  Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Anna Lalik; Graça Soveral
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 7.  Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.

Authors:  Kok-Min Seow; Yi-Wen Chang; Kuo-Hu Chen; Chi-Chang Juan; Chen-Yu Huang; Li-Te Lin; Kuan-Hao Tsui; Yi-Jen Chen; Wen-Ling Lee; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.